Emcure Pharmaceuticals Limited announced that its oncology manufacturing facility in Sanand, Ahmedabad has successfully cleared a Pre-Approval Inspection (PAI) conducted by the US Food and Drug ...

Alright, Sullivan’s Crossing fans, gather ‘round! That Season 3 finale had us all yelling at our screens—Maggie’s got a husband now? What?! If you’re as obsessed with this cozy Canadian drama, you’re ...

Hey, Upload fans! If you’re anything like me, that Season 3 cliffhanger left you reeling, and you’re probably counting down the days until we get some answers in Season 4. The big question on everyone ...

Alright, House of the Dragon fans, let’s talk about Season 3! After that jaw-dropping Season 2 finale, we’re all itching to know what’s next for the Targaryens and their dragon-filled civil war. The ...

In today’s time, India is friendly with several nations. It is unlikely you would name the United States, Japan, Isreal, Bhutan, Afghanistan, Russia. These six nations are having excellent connections ...

Pacifica Hotels G.K. subsidiary Karasuma Hospitality G.K. has signed a franchise agreement with IHG Hotels & Resorts to rebrand a 103-room hotel in a prime Kyoto location to Garner, IHG’s new midscale ...

Protean eGov Technologies has been eliminated from the Government of India’s PAN 2.0 project, a significant blow for the company that previously expressed confidence in securing the mandate. The Rs ...

Alright, Ginny & Georgia fans, let’s talk about the big question: Is Season 4 of Ginny & Georgia actually happening? After that wild Season 3 finale on Netflix (June 5, 2025, anyone?), we’re all dying ...

Jefferies reiterated its ‘Buy’ rating on the stock with a target price of ₹100, stating that a higher HRAB could significantly enhance allowable tariff recovery and profitability for DIAL, addressing ...

Nevada's lenient divorce laws significantly contribute to its standing. The state only requires a six-week residency period to file for divorce, one of the shortest in the USA.

Page Industries shares gained 4% in morning trade after Goldman Sachs initiated a 'Buy' rating on the stock with a steep target of ₹52,000. As of 9:58 AM, the shares were trading 2.47% higher at Rs 46 ...

Glenmark Pharmaceuticals has announced the launch of TEVIMBRA® (tislelizumab) in India, marking its entry into the immuno-oncology space. This anti-PD-1 monoclonal antibody, developed by global ...